APO Research
Talk to an analyst

APO RESEARCH · REPORT

T-Cell & NK-Cell Engaging Bispecific Antibodies

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Analysis and Forecast 2026-2032

29 December 2025191 pages

Choose your research edition.

Industry ResearchT-Cell & NK-Cell Engaging Bispecific Antibodies Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal T-Cell & NK-Cell Engaging Bispecific Antibodies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal T-Cell & NK-Cell Engaging Bispecific Antibodies Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal T-Cell & NK-Cell Engaging Bispecific Antibodies Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global T-Cell & NK-Cell Engaging Bispecific Antibodies market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for T-Cell & NK-Cell Engaging Bispecific Antibodies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for T-Cell & NK-Cell Engaging Bispecific Antibodies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for T-Cell & NK-Cell Engaging Bispecific Antibodies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for T-Cell & NK-Cell Engaging Bispecific Antibodies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies include Immunocore, MacroGenics, Regeneron, AbbVie, Amgen, Pfizer, Roche and Johnson & Johnson, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for T-Cell & NK-Cell Engaging Bispecific Antibodies, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of T-Cell & NK-Cell Engaging Bispecific Antibodies, also provides the sales of main regions and countries. Of the upcoming market potential for T-Cell & NK-Cell Engaging Bispecific Antibodies, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the T-Cell & NK-Cell Engaging Bispecific Antibodies sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global T-Cell & NK-Cell Engaging Bispecific Antibodies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for T-Cell & NK-Cell Engaging Bispecific Antibodies sales, projected growth trends, production technology, application and end-user industry.

T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Company

Immunocore

MacroGenics

Regeneron

AbbVie

Amgen

Pfizer

Roche

Johnson & Johnson

T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Type

T-Cell Engagers

NK-Cell Engagers

T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Application

Hematological Cancers

Solid Tumors

T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global T-Cell & NK-Cell Engaging Bispecific Antibodies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of T-Cell & NK-Cell Engaging Bispecific Antibodies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of T-Cell & NK-Cell Engaging Bispecific Antibodies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of T-Cell & NK-Cell Engaging Bispecific Antibodies in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of T-Cell & NK-Cell Engaging Bispecific Antibodies manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, T-Cell & NK-Cell Engaging Bispecific Antibodies sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. T-Cell Engagers Major Manufacturers Table 3. NK-Cell Engagers Major Manufacturers Table 4. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hematological Cancers Major Manufacturers Table 6. Solid Tumors Major Manufacturers Table 7. T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Trends Table 8. T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Drivers Table 9. T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Opportunities and Challenges Table 10. T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Restraints Table 11. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region (2021-2026) & (US$ Million) Table 13. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region (2027-2032) & (US$ Million) Table 14. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Region (2021-2026) Table 15. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Region (2027-2032) Table 16. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2021-2026) & (K Units) Table 18. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2027-2032) & (K Units) Table 19. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Region (2021-2026) Table 20. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Region (2027-2032) Table 21. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Manufacturers (2021-2026) Table 23. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Manufacturers (2021-2026) Table 25. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturers, Product Type & Application Table 29. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global T-Cell & NK-Cell Engaging Bispecific Antibodies by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2021-2026) & (US$ Million) Table 34. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2027-2032) & (US$ Million) Table 35. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Type (2021-2026) Table 36. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Type (2027-2032) Table 37. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2021-2026) & (K Units) Table 39. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2027-2032) & (K Units) Table 40. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2021-2026) Table 41. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2027-2032) Table 42. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Type (2021-2026) & (US$/Unit) Table 43. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Type (2027-2032) & (US$/Unit) Table 44. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2021-2026) & (US$ Million) Table 46. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2027-2032) & (US$ Million) Table 47. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Application (2021-2026) Table 48. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Application (2027-2032) Table 49. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2021-2026) & (K Units) Table 51. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2027-2032) & (K Units) Table 52. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2021-2026) Table 53. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2027-2032) Table 54. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Application (2021-2026) & (US$/Unit) Table 55. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Application (2027-2032) & (US$/Unit) Table 56. Immunocore Company Information Table 57. Immunocore Business Overview Table 58. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio Table 60. Immunocore Recent Development Table 61. MacroGenics Company Information Table 62. MacroGenics Business Overview Table 63. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio Table 65. MacroGenics Recent Development Table 66. Regeneron Company Information Table 67. Regeneron Business Overview Table 68. Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio Table 70. Regeneron Recent Development Table 71. AbbVie Company Information Table 72. AbbVie Business Overview Table 73. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio Table 75. AbbVie Recent Development Table 76. Amgen Company Information Table 77. Amgen Business Overview Table 78. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio Table 80. Amgen Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio Table 85. Pfizer Recent Development Table 86. Roche Company Information Table 87. Roche Business Overview Table 88. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio Table 90. Roche Recent Development Table 91. Johnson & Johnson Company Information Table 92. Johnson & Johnson Business Overview Table 93. Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio Table 95. Johnson & Johnson Recent Development Table 96. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2021-2026) & (US$ Million) Table 97. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2027-2032) & (US$ Million) Table 98. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2021-2026) & (K Units) Table 99. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2027-2032) & (K Units) Table 100. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Type (2021-2026) & (US$/Unit) Table 101. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Type (2027-2032) & (US$/Unit) Table 102. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2021-2026) & (US$ Million) Table 103. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2027-2032) & (US$ Million) Table 104. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2021-2026) & (K Units) Table 105. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2027-2032) & (K Units) Table 106. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Application (2021-2026) & (US$/Unit) Table 107. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Application (2027-2032) & (US$/Unit) Table 108. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 110. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 111. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 112. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2021-2026) & (K Units) Table 113. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2027-2032) & (K Units) Table 114. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Country (2021-2026) & (US$/Unit) Table 115. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Country (2027-2032) & (US$/Unit) Table 116. United States T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 117. Canada T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 118. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2021-2026) & (K Units) Table 121. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2027-2032) & (K Units) Table 122. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Type (2021-2026) & (US$/Unit) Table 123. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Type (2027-2032) & (US$/Unit) Table 124. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2021-2026) & (US$ Million) Table 125. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2027-2032) & (US$ Million) Table 126. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2021-2026) & (K Units) Table 127. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2027-2032) & (K Units) Table 128. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Application (2021-2026) & (US$/Unit) Table 129. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Application (2027-2032) & (US$/Unit) Table 130. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 132. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 133. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 134. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2021-2026) & (K Units) Table 135. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2027-2032) & (K Units) Table 136. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Country (2021-2026) & (US$/Unit) Table 137. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Country (2027-2032) & (US$/Unit) Table 138. Germany T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 139. France T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 140. U.K. T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 141. Italy T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 142. Netherlands T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 143. Nordic Countries T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 144. China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2021-2026) & (US$ Million) Table 145. China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2027-2032) & (US$ Million) Table 146. China T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2021-2026) & (K Units) Table 147. China T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2027-2032) & (K Units) Table 148. China T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Type (2021-2026) & (US$/Unit) Table 149. China T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Type (2027-2032) & (US$/Unit) Table 150. China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2021-2026) & (US$ Million) Table 151. China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2027-2032) & (US$ Million) Table 152. China T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2021-2026) & (K Units) Table 153. China T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2027-2032) & (K Units) Table 154. China T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Application (2021-2026) & (US$/Unit) Table 155. China T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Application (2027-2032) & (US$/Unit) Table 156. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2021-2026) & (US$ Million) Table 157. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2027-2032) & (US$ Million) Table 158. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2021-2026) & (K Units) Table 159. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2027-2032) & (K Units) Table 160. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Type (2021-2026) & (US$/Unit) Table 161. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Type (2027-2032) & (US$/Unit) Table 162. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2021-2026) & (K Units) Table 165. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2027-2032) & (K Units) Table 166. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Application (2021-2026) & (US$/Unit) Table 167. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Application (2027-2032) & (US$/Unit) Table 168. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 172. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2021-2026) & (K Units) Table 173. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2027-2032) & (K Units) Table 174. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Country (2021-2026) & (US$/Unit) Table 175. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Country (2027-2032) & (US$/Unit) Table 176. Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 177. South Korea T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 178. India T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 179. Australia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 180. China Taiwan T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 181. Southeast Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 182. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2021-2026) & (US$ Million) Table 183. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2027-2032) & (US$ Million) Table 184. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2021-2026) & (K Units) Table 185. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2027-2032) & (K Units) Table 186. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Type (2021-2026) & (US$/Unit) Table 187. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Type (2027-2032) & (US$/Unit) Table 188. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2021-2026) & (US$ Million) Table 189. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2027-2032) & (US$ Million) Table 190. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2021-2026) & (K Units) Table 191. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2027-2032) & (K Units) Table 192. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Application (2021-2026) & (US$/Unit) Table 193. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Application (2027-2032) & (US$/Unit) Table 194. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 198. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2021-2026) & (K Units) Table 199. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2027-2032) & (K Units) Table 200. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Country (2021-2026) & (US$/Unit) Table 201. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Brazil T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 203. Argentina T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 204. Chile T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 205. Colombia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 206. Peru T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 207. Saudi Arabia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 208. Israel T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 209. UAE T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 210. Turkey T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 211. Iran T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 212. Egypt T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors List Table 216. T-Cell & NK-Cell Engaging Bispecific Antibodies Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. T-Cell & NK-Cell Engaging Bispecific Antibodies Image Figure 2. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Share 2021 VS 2025 VS 2032 Figure 4. T-Cell Engagers Image Figure 5. NK-Cell Engagers Image Figure 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hematological Cancers Image Figure 9. Solid Tumors Image Figure 10. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2021-2032) & (US$ Million) Figure 12. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Region (2021-2032) Figure 15. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (2021-2032) & (K Units) Figure 16. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico T-Cell & NK-Cell Engaging Bispecific Antibodies Sales YoY (2021-2032) & (K Units) Figure 19. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales YoY (2021-2032) & (K Units) Figure 20. China T-Cell & NK-Cell Engaging Bispecific Antibodies Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) T-Cell & NK-Cell Engaging Bispecific Antibodies Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales YoY (2021-2032) & (K Units) Figure 23. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Type (2021-2032) Figure 29. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2021-2032) Figure 32. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Application (2021-2032) Figure 35. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2021-2032) Figure 38. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Type (2021-2032) Figure 39. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Type (2021-2032) Figure 40. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Application (2021-2032) Figure 41. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Application (2021-2032) Figure 42. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Country (2021-2032) Figure 43. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Country (2021-2032) Figure 44. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Type (2021-2032) Figure 45. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Type (2021-2032) Figure 46. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Application (2021-2032) Figure 47. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Application (2021-2032) Figure 48. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Country (2021-2032) Figure 49. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Country (2021-2032) Figure 50. China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Type (2021-2032) Figure 51. China T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Type (2021-2032) Figure 52. China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Application (2021-2032) Figure 53. China T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Application (2021-2032) Figure 54. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Type (2021-2032) Figure 55. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Type (2021-2032) Figure 56. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Application (2021-2032) Figure 57. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Application (2021-2032) Figure 58. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Country (2021-2032) Figure 59. Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Country (2021-2032) Figure 60. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Type (2021-2032) Figure 61. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Type (2021-2032) Figure 62. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Application (2021-2032) Figure 63. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Application (2021-2032) Figure 64. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Country (2021-2032) Figure 65. SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Country (2021-2032) Figure 66. T-Cell & NK-Cell Engaging Bispecific Antibodies Value Chain Figure 67. Manufacturing Cost Structure Figure 68. T-Cell & NK-Cell Engaging Bispecific Antibodies Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • T-Cell Engagers
  • NK-Cell Engagers
Applications
  • Hematological Cancers
  • Solid Tumors
Companies covered
  • Immunocore
  • MacroGenics
  • Regeneron
  • AbbVie
  • Amgen
  • Pfizer
  • Roche
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Market by Type
  3. 1.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 T-Cell Engagers
  5. 1.2.3 NK-Cell Engagers
  6. 1.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Market by Application
  7. 1.3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hematological Cancers
  9. 1.3.3 Solid Tumors
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Dynamics
  1. 2.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Trends
  2. 2.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Drivers
  3. 2.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Opportunities and Challenges
  4. 2.4 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region
  3. 3.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region (2021-2026)
  5. 3.2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region (2027-2032)
  6. 3.2.4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Region (2021-2032)
  7. 3.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region
  9. 3.4.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2021-2026)
  11. 3.4.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2027-2032)
  12. 3.4.4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Manufacturers
  2. 4.1.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Manufacturers
  6. 4.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturers, Product Type & Application
  13. 4.7 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market CR5 and HHI
  16. 4.8.2 2025 T-Cell & NK-Cell Engaging Bispecific Antibodies Tier 1, Tier 2, and Tier 3
5 T-Cell & NK-Cell Engaging Bispecific Antibodies Market by Type
  1. 5.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type
  2. 5.1.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Type (2021-2032)
  5. 5.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type
  6. 5.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2021-2032)
  9. 5.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Type
6 T-Cell & NK-Cell Engaging Bispecific Antibodies Market by Application
  1. 6.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application
  2. 6.1.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Application (2021-2032)
  5. 6.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application
  6. 6.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2021-2032)
  9. 6.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Application
7 Company Profiles
  1. 7.1 Immunocore
  2. 7.1.1 Immunocore Company Information
  3. 7.1.2 Immunocore Business Overview
  4. 7.1.3 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
  6. 7.1.5 Immunocore Recent Developments
  7. 7.2 MacroGenics
  8. 7.2.1 MacroGenics Company Information
  9. 7.2.2 MacroGenics Business Overview
  10. 7.2.3 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
  12. 7.2.5 MacroGenics Recent Developments
  13. 7.3 Regeneron
  14. 7.3.1 Regeneron Company Information
  15. 7.3.2 Regeneron Business Overview
  16. 7.3.3 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
  18. 7.3.5 Regeneron Recent Developments
  19. 7.4 AbbVie
  20. 7.4.1 AbbVie Company Information
  21. 7.4.2 AbbVie Business Overview
  22. 7.4.3 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
  24. 7.4.5 AbbVie Recent Developments
  25. 7.5 Amgen
  26. 7.5.1 Amgen Company Information
  27. 7.5.2 Amgen Business Overview
  28. 7.5.3 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
  30. 7.5.5 Amgen Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 Roche
  38. 7.7.1 Roche Company Information
  39. 7.7.2 Roche Business Overview
  40. 7.7.3 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
  42. 7.7.5 Roche Recent Developments
  43. 7.8 Johnson & Johnson
  44. 7.8.1 Johnson & Johnson Company Information
  45. 7.8.2 Johnson & Johnson Business Overview
  46. 7.8.3 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
  48. 7.8.5 Johnson & Johnson Recent Developments
8 North America
  1. 8.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type
  2. 8.1.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2021-2032)
  3. 8.1.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2021-2032)
  4. 8.1.3 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Type (2021-2032)
  5. 8.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application
  6. 8.2.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2021-2032)
  7. 8.2.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2021-2032)
  8. 8.2.3 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Application (2021-2032)
  9. 8.3 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country
  10. 8.3.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type
  2. 9.1.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2021-2032)
  3. 9.1.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2021-2032)
  4. 9.1.3 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Type (2021-2032)
  5. 9.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application
  6. 9.2.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2021-2032)
  7. 9.2.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2021-2032)
  8. 9.2.3 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Application (2021-2032)
  9. 9.3 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country
  10. 9.3.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type
  2. 10.1.1 China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2021-2032)
  3. 10.1.2 China T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2021-2032)
  4. 10.1.3 China T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Type (2021-2032)
  5. 10.2 China T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application
  6. 10.2.1 China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2021-2032)
  7. 10.2.2 China T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2021-2032)
  8. 10.2.3 China T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type
  2. 11.1.1 Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2021-2032)
  3. 11.1.2 Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2021-2032)
  4. 11.1.3 Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Type (2021-2032)
  5. 11.2 Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application
  6. 11.2.1 Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2021-2032)
  7. 11.2.2 Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2021-2032)
  8. 11.2.3 Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Application (2021-2032)
  9. 11.3 Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country
  10. 11.3.1 Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type
  2. 12.1.1 SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2021-2032)
  4. 12.1.3 SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Type (2021-2032)
  5. 12.2 SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application
  6. 12.2.1 SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2021-2032)
  8. 12.2.3 SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Application (2021-2032)
  9. 12.3 SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country
  10. 12.3.1 SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Value Chain Analysis
  2. 13.1.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 T-Cell & NK-Cell Engaging Bispecific Antibodies Production Mode & Process
  6. 13.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors
  9. 13.2.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst